Roche targets double-digit market share in weight loss, aims to catch up with Novo Nordisk, Handelsblatt reports

Company Strategy - Roche aims for a double-digit market share in the weight loss market, seeking to close the gap with its competitor Novo Nordisk [1] - The CEO of Roche, Thomas Schinecker, expressed the expectation to be among the top three players in the market at the very least [1]